针对宫癌的免疫微环境:当前的研究和进展
Zhen Zhang1, Miao Liu2, Yu An2
1Department of Abdominal and Pelvic Tumor Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450000, Henan, China.
Journal of translational medicine
|August 9, 2025
概括
宫癌中的瘤免疫微环境 (TIME) 涉及各种免疫细胞和分子. 针对TIME提供了有希望的策略,以改善宫癌患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症研究 癌症研究
背景情况:
- 瘤免疫微环境 (TIME) 对宫癌的发展和治疗反应至关重要.
- 了解TIME的细胞和分子成分是推进治疗策略的关键.
研究的目的:
- 综合审查子宫癌的组成部分,包括免疫细胞透,免疫检查点和细胞因子网络.
- 用空间映射和单细胞测序来突出理解 TIME 异质性的进展.
- 评估目前和新兴的宫癌免疫治疗策略.
主要方法:
- 对宫癌的临床前和临床研究的系统综述 时间.
- 对免疫细胞透模式 (T细胞,B细胞,NK细胞,DC,TAM) 的分析.
- 检查免疫检查点分子和细胞因子/化学因子网络.
主要成果:
- 宫癌中免疫细胞群和分子介质的详细表征 时间.
- 洞察不同疾病阶段和治疗方式的TIME异质性.
- 评估免疫疗法,如免疫检查点抑制剂,采用细胞疗法和疫苗.
结论:
- 准宫癌 时间具有显著的翻译潜力,可以改善患者的治疗结果.
- 技术的进步正在提高我们对时间复杂性的理解.
- 需要进一步的研究来优化免疫治疗策略.
相关概念视频
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
Cancer Vaccines
509
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
509
Cytotoxic T Cells-mediated Immune Response
2.0K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
2.0K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K


